The global contrast media injectors market is expected to reach USD 2.0 billion by 2030, registering a CAGR of 7.4% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.
COVID-19 had a significant impact on the contrast media injector market, in 2019, with around a 30-40% reduction in sales due to the imposed lockdown and rapid decline in imaging case volume. However, the market is expected to return to peak levels of 2019 by 2022. This is due to the launch of COVID-19 vaccines and ease in restrictions, import & export of raw materials have resumed; therefore, the market is expected to grow at a significant rate over the forecast period.
Technological advancements such as IT-enabled solutions for contrast media injectors, along with growing demand for minimally invasive surgical procedures, are expected to boost the market during the coming years. Furthermore, the large number of intraoperative imaging procedures being performed has further enhanced the demand for these injectors, propelling the market growth.
Request a free sample copy or view report summary: Contrast Media Injector Market Report
By product, injector systems accounted for the largest market share of 60.9% in 2022, due to its growing application in the diagnosis and treatment of vascular disease, cancer, and others
By type, single head injectors accounted for the largest market share of 44.0% in 2022, because of their wide usage in the field of angiography, CT, and MRI as well these products are inexpensive
Based on the application, the radiology segment dominated the market with around 47.1% of the revenue share in 2022, because it is the primary procedure used for the diagnosis of several chronic diseases
Based on the end use, the hospitals segment dominated the market with around 68.2% of the revenue share in 2022, due to the fact that these facilities are primary users of the contrast media injectors because of their need to record the rhythm & electrical activity and evaluate the results in detail for clinical & research purposes
Asia Pacific contrast media injectors market is expected to witness the fastest growth rate at a CAGR of 8.5% over the forecast period. Factors that can be attributed to market growth include the growing geriatric population and an increasing number of surgeries
Grand View Research has segmented the global contrast media injectors market on the basis of product, type, application, end use, and region:
Contrast Media Injectors Product Outlook (Revenue USD Million; 2016 - 2030)
Injector Systems
CT injector systems
MRI injector systems
Cardiovascular/angiography injector systems
Consumables
Tubing
Syringe
Others
Contrast Media Injectors Type Outlook (Revenue USD Million; 2016 - 2030)
Single Head Injectors
Dual-Head Injectors
Syringeless Injectors
Contrast Media Injectors Application Outlook (Revenue USD Million; 2016 - 2030)
Radiology
Interventional Cardiology
Interventional Radiology
Contrast Media Injectors End Use Outlook (Revenue USD Million; 2016 - 2030)
Hospitals
Diagnostics Centers
Ambulatory Surgery Centers
Contrast Media Injectors Regional Outlook (Revenue, USD Million, 2016 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Contrast Media Injectors Market
Bayer HealthCare LLC
Bracco Group
Ulrich Medical
Guerbet Group
Medtron AG
Nemoto Kyorindo Co., Ltd.
Hong Kong Medi Co Limited
"The quality of research they have done for us has been excellent..."